Mozaffarieh Maneli, Benesch Thomas, Sacu Stefan, Krepler Katharina, Biowski Robert, Wedrich Andreas
Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Acta Ophthalmol Scand. 2005 Jun;83(3):316-21. doi: 10.1111/j.1600-0420.2005.00455.x.
To assess satisfaction with photocoagulation treatment in diabetes patients and to investigate how it relates to patient-related characteristics and patients' visual ability. Further, to observe the interaction between physician and patient and suggest ways to improve the patient-provider relationship and, thereby, treatment satisfaction.
This open longitudinal study included 123 diabetes patients undergoing first photocoagulation treatment for diabetic maculopathy or proliferative retinopathy. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) was completed by all patients. Communication, scheduling and adherence scores were defined for each physician-patient pair. Outcome measures were: the patient's overall satisfaction with laser treatment; the patient's degree of satisfaction in relation to visual results; communication, scheduling and adherence scores, and visual acuity results.
The level of satisfaction after initial photocoagulation treatment was high; 46.4% of patients with proliferative retinopathy and 53.1% with maculopathy scored 31 or higher. Although 69.5% of all patients reported that their expectations of treatment corresponded to their final 9-month visual results, only 8.7% of these patients reported an improvement in visual acuity after 9 months. The number of unwanted actions performed by the patients during treatment were significantly related to the number of unclear instructions given by the physician (Fisher's exact test P < 0.01).
A high level of satisfaction was observed, despite the minimal improvements in visual acuity. Attempts to further improve patient satisfaction might focus on improved education of patients on the possible benefits of laser treatment, greater care in communicating information during treatment, additional nursing support, and additional clerical time to communicate with patients before each appointment.
评估糖尿病患者对光凝治疗的满意度,并调查其与患者相关特征及视觉能力之间的关系。此外,观察医患之间的互动,并提出改善医患关系从而提高治疗满意度的方法。
这项开放性纵向研究纳入了123名因糖尿病性黄斑病变或增殖性视网膜病变首次接受光凝治疗的糖尿病患者。所有患者均完成了糖尿病治疗满意度问卷(DTSQ)。为每对医患定义了沟通、预约安排和依从性评分。观察指标包括:患者对激光治疗的总体满意度;患者对视觉效果的满意程度;沟通、预约安排和依从性评分,以及视力结果。
初次光凝治疗后的满意度较高;增殖性视网膜病变患者中有46.4%、黄斑病变患者中有53.1%的评分达到31分或更高。尽管所有患者中有69.5%报告称他们对治疗的期望与最终9个月时的视觉结果相符,但这些患者中只有8.7%报告在9个月后视力有所改善。患者在治疗期间执行的不必要操作的数量与医生给出的不清晰指示的数量显著相关(Fisher精确检验P<0.01)。
尽管视力改善甚微,但仍观察到较高的满意度。进一步提高患者满意度的尝试可能集中在加强对患者激光治疗潜在益处的教育、治疗期间更谨慎地传达信息、增加护理支持,以及每次预约前增加与患者沟通的文书时间。